Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
20% zinc oxide ointment versus 80% trichloroacetic acid for genital warts
IRCT20220816055716N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anogenital warts comparing 20% zinc oxide ointment with 80% trichloroacetic acid solution (2 arms). Primary endpoints: Number of genital warts and Size of genital warts. Started Sep 2022; status: completed.
02
Drugs
zinc oxidetrichloroacetic acid
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20220816055716N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220816055716N1.